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Extracellular matrixDuring ageing, the function of sinoatrial node (SAN), the pacemaker of the heart, declines, and the incidence
of sick sinus syndrome increases markedly. The aim of the study was to investigate structural and functional
remodelling of the SAN during ageing. Rats, 3 and 24 months old (equivalent to young adult and ∼69-year-
old humans), were studied. Extracellular potential recording from right atrial preparations showed that (as
expected) the intrinsic heart rate was slower in the old animals. It also showed a shift of the leading
pacemaker site towards the inferior vena cava in the old animals. Consistent with this, intracellular potential
recording showed that slow pacemaker action potentials were more widespread and extended further
towards the inferior vena cava in old animals. Immunohistochemistry demonstrated that SAN tissue
expressing HCN4, but lacking the expression of Nav1.5 (lack of Nav1.5 explains why pacemaker action
potential is slow), was also more widespread and extended further towards the inferior vena cava in the old
animals. Immunolabelling of caveolin3 (expressed in cell membrane of cardiac myocytes) demonstrated that
there was a hypertrophy of the SAN cells in the old animals. Histology, quantitative PCR, and
immunohistochemistry revealed evidence of a substantial age-dependent remodelling of the extracellular
matrix (e.g. ∼79% downregulation of genes responsible for collagens 1 and 3 and ∼52% downregulation of
gene responsible for elastin). It is concluded that the age- (and/or obesity-) dependent decline in SAN
function is associated with a structural remodelling of the SAN: an enlargement of the SAN, a hypertrophy of
the SAN cells, and a remodelling of the extracellular matrix.
Crown Copyright © 2009 Published by Elsevier Ltd. Open access under CC BY license.1. Introduction
Cardiovascular disease is a leading cause of morbidity and
mortality and it occurs with increasing incidence in the elderly [1].
The function of the sinoatrial node (SAN), the pacemaker of the heart,
declines with age – there is a decrease in the intrinsic heart rate (heart
rate in absence of autonomic tone) and an increase in the SAN
conduction time [2]. There is also a strong correlation between ageing
and the incidence of sick sinus syndrome [2]. Manifestations of sick
sinus syndrome include bradycardia, SAN arrest, and SAN exit block
[2]. The mechanisms underlying the age-dependent decline in SAN
function are unclear.
There is evidence that ageing is associated with a structural
remodelling of the SAN. First, there is electrophysiological evidence of
an enlargement of the SAN: Alings and Bouman [3] showed that, in the
rabbit and cat, the SAN region with a ‘slow action potential’ increases
with age—it has been suggested that this is responsible for the decline
in SAN function [4]. There is a slow action potential in the centre of the
SAN, because there is little or no Na+ current, INa, and the action
potential has a slow upstroke generated by the L-type Ca2+ current,(H. Dobrzynski).
vier Ltd. Open access under CC BY licewhereas in working myocardium the action potential has a fast
upstroke generated by INa. Secondly, there is evidence of a change in
the interstitium (ﬁbroblasts and extracellularmatrix). Throughout the
heart, ageing is associated with changes in the interstitium, which
functions as a support for cardiac myocytes and blood vessels and also
maintains myocardial mass, structure, and function [5]. Histologically,
the SAN is distinguished from the surrounding atrial muscle (and
working myocardium in general) by a remarkably large amount of
interstitium (for example, up to 75%–90% of SAN volume in cat [6]).
The function of the interstitium in the SAN is still unclear; it may serve
as a mechanical support and give the SAN the stiffness that it lacks
because of the poor development of the contractile apparatus in SAN
cells [7]. It has been suggested that the age-dependent decline in SAN
function is the result of a loss of nodal cells and a compensatory
proliferation of the interstitium [8,9]. The aim of this study was to
study the changes in the structure and function of the SAN during
ageing.
2. Materials and methods
Right atrial preparations from male Wistar-Hanover rats aged 3
and 24 months (equivalent to young adult and ∼69-year-old humans,
respectively [10]) were used. SAN function was studied using
extracellular potential and intracellular action potential recording.nse.
Fig. 1. Effect of ion channel blockers on spontaneous cycle length of right atrial
preparations from young and old animals. (A) Cycle length: under control conditions
and after application of 100 nM TTX (blocker of Nav1.1) and subsequent application of
2 μM TTX (blocker of Nav1.5) (1–6); under control conditions and after application of
2 mM Cs+(blocker of HCN4) (7–10); and under control conditions and after
application of 10 and 30 μM ivabradine (another blocker of HCN4) (11–16). The
numbers indicate signiﬁcant differences from the appropriately numbered bars
(Pb0.05; one-way ANOVA). (B) Mean (+SEM; n=6) percentage change in cycle
length after blockade of Nav1.1 by 100 nM TTX, blockade of Nav1.5 by subsequent
application of 2 μM TTX, and blockade of HCN4 by 2 mM Cs+ and 10 and 30 μM
ivabradine in young and old animals. ⁎Signiﬁcantly different (Pb0.05) from
corresponding data from young animals (one-way ANOVA).
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istry and quantitative PCR (qPCR), respectively. Collagen protein was
studied using Picro Sirius red staining. The methods are described in
full in the Data Supplement.
3. Results
Old animals were heavier than young animals and their hearts
were also heavier (Data Supplement, Fig. S1). However, there was a
signiﬁcant decrease in the heart-to-body weight ratio (Data Supple-
ment, Fig. S1). In the anaesthetised rat, the normal heart rate is not
signiﬁcantly different between young and old animals (aged 3 and
25months) [10]. Thenormal heart rate is set by the autonomic nervous
system, and therefore, it is important to measure the intrinsic heart
rate. This was measured in isolated right atrial preparations (using
extracellular potential recording from dorsal epicardial surface). The
intrinsic heart rate in old animals was slower (i.e. spontaneous cycle
length was longer) than in young animals (Data Supplement, Fig. S1).
The spontaneous cycle lengthwas297±9ms (n=7) in young animals
and 351±13 ms (n=6) in old animals (t test; Pb0.05).
3.1. Age-dependent increase in sensitivity to blockade of Nav1.5
and HCN4
The age-dependent decline in SAN function has been suggested to
be the result of a decline in INa (see Introduction). This is a possibility,
because blockade of INa can slow pacemaking and familial sick sinus
syndrome has been linked to mutations in Nav1.5 (main ion channel
responsible for INa), although paradoxically there is little or no INa and
Nav1.5 in the centre of the SAN [2]. Another possibility is that it is the
result of a decline in the funny current, If, because blockade of If slows
pacemaking and familial sick sinus syndrome has also been linked to
mutations in HCN4 (main ion channel responsible for If) [2]; If and
HCN4 are present in the SAN [2]. To test these possibilities, the effect
of blockade of Nav1.5 and HCN4 on the spontaneous activity of right
atrial preparations was investigated—if the age-dependent decrease
in the intrinsic heart rate is the result of a decline in either INa or If,
blockade of the corresponding ion channel should have a smaller
effect on the heart rate in the older animal. TTX was used to block
Nav1.5. ‘Neuronal Na+ channels’, such as Nav1.1, which have a high
sensitivity to TTX, as well as the cardiac Na+ channel, Nav1.5, which
has a low sensitivity to TTX, are responsible for INa [11]. Blockade of
neuronal Na+ channels by 100 nM TTX caused small changes in cycle
length (signiﬁcantly different in young and old preparations; Fig. 1).
The subsequent application of 2 μM TTX to block Nav1.5 caused a
slowing of pacemaking in both young and old preparations (Fig. 1A) –
however, the percentage increase of the spontaneous cycle lengthwas
signiﬁcantly greater in the old preparations (Fig. 1B). HCN4 was
blocked by the application of 2mM Cs+ or 10 μM ivabradine. Blockade
of If by 2 mM Cs+ is nearly selective and complete [12]. In rabbit SAN
cells at least, 10 μM ivabradine causes 81% blockade of If and a slight
decrease in ICa,L and IK,r [13]. Both 2 mM Cs+ and 10 μM ivabradine
caused a slowing of pacemaking in both young and old preparations
(Fig. 1A) – however, the percentage increase of the spontaneous cycle
length was signiﬁcantly greater in the old preparations (Fig. 1B).
Thirty micromolars of ivabradine was also used – the slowing of
pacemaking was greater in both young and old preparations, but the
effect was still signiﬁcantly greater in the old preparations (Fig. 1).
Thirty micromolars of ivabradine is expected to cause greater
blockade of If (93%); however, the non-speciﬁc effects of 30 μM
ivabradine will be greater [13] (in patients, target plasma concentra-
tion of ivabradine is only ∼0.7 μM). In summary, there is an age-
dependent increase rather than decrease in the sensitivity of the
pacemaker activity of the SAN to blockade of Nav1.5 and HCN4, and
therefore, it is unlikely that the age-dependent decrease in the
intrinsic heart rate is the result of a decline in INa or If.3.2. Age-dependent increase in pacemaker tissue with ‘slow
action potential’
Two lines of evidence showed that there was an age-dependent
increase in pacemaker tissue. In both young and old animals, the leading
pacemaker site (determined by extracellular potential recording) was
located next to the atrial muscle of the crista terminalis. In all young
animals, the leading pacemaker site was located near the superior vena
cava, whereas in old animals, the position of the leading pacemaker site
was generally more inferior and located closer to the inferior vena cava:
in young animals, the leadingpacemaker sitewas1.0±0.4mmfrom the
superior vena cava, whereas in old animals, it was 2.5±0.4 mm (24±
11% and 57±12%, respectively, of the distance between superior and
inferior vena cava) (Table 1).
Intracellular action potential recordings from the dorsal epicar-
dial surface of right atrial preparations revealed three types of cell
(Fig. 2A): ﬁrst, atrial cells with a ‘fast action potential’. Atrial cells
had a stable resting potential and an action potential with a fast
upstroke, large amplitude, and short duration; in young prepara-
tions, the maximum upstroke velocity (dV/dtmax) was 131±8 V/s,
Table 1
Characteristics relating to SAN in young and old animals.
Young animals Old animals t test
Distance from superior to inferior vena cava 4.5±0.3 mm (n=7) 4.7±0.3 mm (n=6) Not signiﬁcant
Distance of leading pacemaker site from superior vena cava 1.0±0.4 mm (n=7) 2.5±0.4 mm (n=6) Pb0.05
Extent of pacemaking tissue along SAN artery 1.7±0.2 mm (n=6) 3.1±0.3 mm (n=7) Pb0.01
Length of Nav1.5-negative/HCN4-positive main tail of SAN 2±0.2 mm (n=5) 2.7±0.3 mm (n=5) Pb0.05
Total volume of Nav1.5-negative/HCN4-positive tissue in SAN head and tails 0.48±0.06 mm3 (n=5) 0.94±0.07 mm3 (n=5) Pb001
Means ± SEM (n) are shown.
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duration at 15% repolarization (APD15) was 6±0.5 ms (n=6; Fig. 2A).
Secondly, ‘true’ pacemaker cells with a ‘slow action potential’. The cells
had a prominent pacemaker potential, a smooth transition from the
pacemaker potential to the actionpotential, and anaction potentialwith
a slow upstroke, small amplitude, and long duration; in young
preparations, dV/dtmax was 11±1 V/s, action potential amplitude was
45±2 mV, and APD15 was 29±2 ms (n=6; Fig. 2A). Thirdly, latent
pacemaker cells with a modest pacemaker potential, an abrupt
transition from the pacemaker potential to the action potential, and an
action potential with an intermediate upstroke velocity, amplitude, and
duration; in young preparations, dV/dtmax was 42±4 V/s, action
potential amplitude was 60±2 mV, and APD15 was 20±1 ms (n=6;
Fig. 2A). Fig. 2B shows the distribution of the three cell types in
preparations from a young and old animal. As in a previous study [14],
the pacemaker cells were distributed along the SAN artery next to the
crista terminalis. In young animals, true and latent pacemaker cellswereFig. 2. Pacemaker tissue is more widespread in old animals. (A) Typical intracellular action po
latent pacemaker, and true pacemaker cells. Recordings shown were obtained from differe
concerning activation times. (B) Photographs of dorsal surface of right atrial preparations
recorded. Blue circles, sites at which latent pacemaker action potentials were recorded. R
terminalis; IVC, inferior vena cava; RA, right atrial free wall; SVC, superior vena cava. Yellowgenerally located in a small region near the superior vena cava, whereas
in old animals, they were more widely distributed and occurred more
inferiorly (Fig. 2B), consistent with the location of the leading
pacemaker site as discussed above. In young animals, pacemaker tissue
extended along the SANartery for 1.7±0.2mm,whereas in old animals,
it extended for 3.1±0.3 mm (47% and 65%, respectively, of distance
between superior and inferior vena cava) (Table 1).
During ageing, as discussed elsewhere [10], there was no
signiﬁcant change in dV/dtmax and APD15, but there was a signiﬁcant
increase (22%) in action potential duration at 75% repolarization in
true and latent pacemaker cells.
3.3 Age-dependent increase in pacemaker tissue lacking expression of
Nav1.5 and expressing HCN4
The SAN has a slow action potential, because Nav1.5 is not
expressed in the SAN [2]. To test whether the age-dependent increasetential recordings (top) and rate of change of membrane potential (bottom) from atrial,
nt animals (one young and two old animals); therefore, no inferences can be drawn
from young and old animals. Black circles, sites at which atrial action potentials were
ed circles, sites at which true pacemaker action potentials were recorded. CT, crista
, SAN artery.
Fig. 3. Nav1.5 expression. (A and B) immunolabelling of Nav1.5 (green signal) in sections through head of SAN in young (A) and old (B) animals. Yellow dashed lines, border of tissue
sections; white dashed lines, border between Nav1.5 expressing and non-expressing regions. (C) High-power image of immunolabelling of Nav1.5 in atrial muscle. Yellow arrow
highlights immunolabelling of Nav1.5 in cell membrane. L, left; R, right; SVC, superior vena cava.
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increase in Nav1.5-negative tissue, cryosections were cut (in plane of
short axis of heart) from the superior towards the inferior vena cava.
For young and old animals, 10 to 15 sections at 200 μm intervals were
immunolabelled for Nav1.5 and adjacent sections were immunola-
belled for HCN4. Fig. 3 shows Nav1.5 labelling and Fig. 4 shows HCN4
labelling at the level of the superior vena cava in young and old
animals. Nav1.5 was expressed in much of the tissue section (Figs. 3A
and B) – it was expressed in the cell membrane as shown in the high-
magniﬁcation image in Fig. 3C. However, in one region, Nav1.5 was
not expressed (outlined with dotted white line in Figs. 3A and B). InFig. 4. HCN4 expression. (A and B) immunolabelling of HCN4 (green signal) in sections thro
sections; white dashed lines, border between HCN4 expressing and non-expressing region
immunolabelling of HCN4 in cell membrane. L, left; R, right; SVC, superior vena cava.contrast, HCN4 was only expressed in one region (outlined with
dotted white line in Figs. 4A and B); in this region, it was expressed in
the cell membrane as shown in Fig. 4C. Comparison of Figs. 3 and 4
shows that the tissue expressing Nav1.5 lacked expression of HCN4
and was, therefore, atrial muscle, whereas the tissue lacking
expression of Nav1.5 expressed HCN4 and was, therefore, nodal. The
Nav1.5-negative/HCN4-positive region in Figs. 3 and 4 was larger in
the old animal. The Nav1.5-negative/HCN4-positive region also did
not express the gap junction channel, Cx43 (data not shown).
The shaded areas in Fig. 5A show schematically the distribution of
Nav1.5-negative/HCN4-positive SAN tissue. The SAN is made up of augh head of SAN in young (A) and old (B) animals. Yellow dashed lines, border of tissue
s. (C) High-power image of immunolabelling of HCN4 in SAN. Yellow arrows highlight
Fig. 5. (A) Dorsal view of right atrium. SAN is shaded and forms inverted ‘U’. (B) Mean (±SEM; n=5) area of Nav1.5-negative/HCN4-positive tissue at different levels of main SAN
tail in young and old animals. Area plotted against distance of tissue section from superior vena cava (SVC). IVC, inferior vena cava; RA, right atrial free wall.
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tail extending down the side of the crista terminalis (and centred on
SAN artery; Fig. 5A). There is a second smaller tail extending down the
groove between the right and left atria (Fig. 5A). We have previously
shown HCN4-positive tissue to be distributed in this manner in the
young rat [15]. The sections shown in Figs. 3 and 4 are from the head.
In old animals, the Nav1.5-negative/HCN4-positive region was larger
in the main tail as well as head of the SAN: Fig. 5B shows the area of
the Nav1.5-negative/HCN4-positive region in themain tail at different
distances from the superior vena cava. Fig. 5B shows that the main tail
was also longer in the old animals; in young and old animals, it was
45% and 57%, respectively, of the distance between the superior and
inferior vena cava (Table 1).
The total volume of Nav1.5-negative/HCN4-positive tissue in the
head and the two tails was estimated from data like those in Fig. 5B
and was 97% greater in old animals (Table 1). The total volume of
Nav1.5-negative/HCN4-positive tissue as a percentage of the volume
of the heart (estimated from heart weight) did not change
signiﬁcantly with age (0.04±0.007%, n=5, and 0.05±0.003%,
n=5, in young and old animals, respectively).
3.4. Why is the leading pacemaker site located in the tail of SAN?
Why is the leading pacemaker site always located in themain tail of
Nav1.5-negative/HCN4-positive tissue next to the crista terminalis
rather than the large head of Nav1.5-negative/HCN4-positive tissue in
the ventral wall of the superior vena cava? The functional importance
of the head and tail of the SAN was investigated in six right atrial
preparations from young animals. In the intact preparations, the
spontaneous cycle length was measured and the position of the
leading pacemaker site was determined—the leading pacemaker site
was located in the tail of the SAN next to the crista terminalis as
observed previously. The superior vena cava was then separated from
the right atrium in order to separate the SAN head from the SAN tail. In
all six cases, the remaining right atrium (corresponding to SAN tail)
continued to show spontaneous activity (spontaneous cycle length
was shorter than in intact preparations–Data Supplement, Fig. S2) and
the leading pacemaker site was shifted inferiorly (data not shown). In
only two of the cases did the superior vena cava (corresponding to SAN
head) show spontaneous activity – furthermore, the mean spontane-
ous cycle length of these two preparations was longer than that of the
remaining right atrium (Data Supplement, Fig. S2). Isoproterenol, at
0.05 μM, decreased the spontaneous cycle length of both the two
superior vena cava preparations that showed spontaneous activity aswell as all the remaining right atrial preparations (Data Supplement,
Fig. S2). Finally, when recording intracellular action potentials from
the SANhead,wewere only able to recordpacemaker actionpotentials
from one of four preparations (from old animals). It is concluded that
the SAN tail and not the SANhead shows robust pacemaking and this is
why the leading pacemaker site is always located in the SAN tail. Why
this should be the case is not known.
3.5. Age-dependent enlargement of Nav1.5-negative/HCN4-positive
tissue can be explained by hypertrophy of SAN cells
Fig. 6A shows high-magniﬁcation images of Masson's trichrome
stained sections of the SAN and atrial muscle (different tissue types
were identiﬁed by characteristic pattern of expression of Nav1.5 and
HCN4 in adjacent tissue sections) in a young and old animal – it shows
that the SAN cells were smaller than the atrial cells and both cell types
were larger in the old animal. To conﬁrm this, sections were
immunolabelled for caveolin3 to highlight the cell membrane in
order to measure the cell diameter (Fig. 6B). In old animals, cell
diameter was signiﬁcantly increased by 38% and 23% in the SAN and
atrial muscle, respectively (Fig. 6C). The total volume of the SAN is
proportional to the SAN cell volume (if the number of SAN cells is
constant) and cell volume is proportional to the square of the cell
radius (if cell length remains unchanged). Calculation shows that the
increase in SAN cell diameter of 38% is expected to increase the volume
of the SAN by 90% and this is similar to that observed experimentally
(97%).
3.6. Age-dependent remodelling of interstitium
To test if there is an age-dependent remodelling of the interstitium
of the SAN during ageing, the abundance of mRNAs for important
interstitial components was measured using qPCR. The two main
components of the interstitium are ﬁbroblasts and the extracellular
matrix (principally collagens) [9]. Vimentin is expressed by ﬁbro-
blasts (as well as other cell types) [16]; as expected, vimentin mRNA
wasmore abundant in the SAN than in the atrial muscle (Fig. 7A). This
is consistent with the ﬁbroblasts being more numerous in the SAN
than in the atrial muscle. However, there was no age-dependent
change in vimentin mRNA (Fig. 7A). Immunolabelling of vimentin
(Data Supplement, Fig. S3) also revealed no age-dependent change in
vimentin at the protein level (Fig. 7B). These data suggest that there
was no age-dependent change in the number of ﬁbroblasts in the SAN.
Collagens are structural proteins made by the ﬁbroblasts. Types 1 and
Fig. 6. Change in cell diameter with age. (A) High-magniﬁcation images of SAN and atrial muscle (stained with Masson's trichrome) from young and old animals. (B)
Immunolabelling of caveolin3 in SAN and atrial muscle in young and old animals. Caveolin3 is expressed in cell membrane in both SAN and atrial muscle. From images such as these,
we measured cell diameter. (C) Mean (+SEM; n=4 animals; ∼25 cells/animal measured) cell diameter of SAN and atrial cells in young and old animals. Numbers denote
statistically signiﬁcant differences (Pb0.05) from appropriately numbered bars (one-way ANOVA).
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Fig. 7. Age-dependent remodelling of interstitium. (A) Relative abundance of mRNAs for various components of interstitium in SAN and atrial muscle of young and old animals.
Means+SEM (n=8) shown. (B) Mean (+SEM; n=4) density of vimentin protein immunolabelling in SAN and atrial muscle of young and old animals. (C) Mean (+SEM; n=4)
density of Picro Sirius red staining of collagen in SAN and atrial muscle of young and old animals. Numbers denote statistically signiﬁcant differences (Pb0.05) from appropriately
numbered bars (two-way ANOVA). RA, right atrial free wall.
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interstitium in the heart [17]. In young animals, like vimentin
mRNA, mRNAs for types 1 and 3 collagens were more abundant in
the SAN than in the atrial muscle (Fig. 7A). Because mRNAs for
vimentin and types 1 and 3 collagens are produced by the ﬁbroblasts,
it is possible that they will vary together. In Figs. 8A and B, the ﬁlled
symbols (and solid lines) show the relationship between the
abundance of mRNA for types 1 and 3 collagens and the abundance
of vimentin mRNA in young animals (each point corresponds to
different animal or region – SAN head, SAN tail, or atrial muscle);
there is a signiﬁcant correlation as expected. However, unlike
vimentin mRNA, there was a substantial and signiﬁcant age-
dependent decrease of mRNAs for types 1 and 3 collagens (Fig. 7A).
In Figs. 8A and B, the open symbols (and dashed lines) show that there
is still a signiﬁcant correlation between the abundance of collagen and
vimentin mRNAs in the old animals, but the relationship is depressed
as compared to that in the young animals. As a result of these changes,
in the old animals, the ratio of collagen type 1 mRNA to vimentin
mRNA was depressed (Data Supplement, Fig. S4). The density of total
collagen proteinwas determined by Picro Sirius red staining of sections
from young and old animals (Data Supplement, Fig. S3). This showed
that the density of collagen protein was higher in the SAN than in theFig. 8. (A, B) Relationship between relative abundance of collagen 1 (A) or collagen 3
(B) mRNA and relative abundance of vimentin mRNA in young (ﬁlled symbols) and old
(open symbols) animals. (C) Relationship between relative abundance of collagen 1
mRNA and relative abundance of collagen 3 mRNA. Data from eight young and old
animals and three tissue types shown. Data ﬁt with straight lines by linear regression
(R2 and P values shown).atrial muscle as expected, and in both tissues, there was a signiﬁcant
age-dependent decrease in the density of collagen protein (Fig. 7C);
this is consistent with the mRNA data (Fig. 7A). It has been reported
that the ratio of collagen 1 (which is stiff) to collagen 3 (which is
elastic) can change in disease [18]. For example, in diseased human
ventricle, the proportion of collagen 1 increases, whereas the
proportion of collagen 3 decreases, and this explains the increase in
passive myocardial stiffness [19]. Fig. 8C shows the relationship
between collagens 1 and 3 in the SAN and atrial muscle of the young
and old animals; all the data lie along a single straight line and this
indicates that the ratio of collagen 1 to collagen 3 does not change with
age in the rat heart.
Another structural protein of the extracellular matrix is elastin.
Once again, elastin mRNA was more abundant in the SAN than in the
atrial muscle (Fig. 7A). As in the case of the collagenmRNAs, therewas
an age-dependent decrease in elastin mRNA (Fig. 7A). The ratio of
collagen 1 mRNA to elastin mRNAwas roughly constant and it did not
vary signiﬁcantly with region or age (Data Supplement, Fig. S4).
Transforming growth factor β1 (TGFβ1) and tumour necrosis factor α
(TNFα) are ﬁbrotic agents: they promote the formation of extracel-
lular matrix including collagens (regulated at transcriptional level)
[20,21]. The abundance of TGFβ1 and TNFαmRNAs was similar in all
tissues (Fig. 7A). There was a signiﬁcant, but modest, age-dependent
upregulation of TGFβ1 and TNFαmRNAs in one of the tissues at least
(Fig. 7A). Metalloproteinases (MMPs) are a group of enzymes that
catalyse the degradation of the extracellular matrix including
collagens [22]. MMP2 is an important cardiac metalloproteinase [23].
The abundance ofMMP2mRNAwas similar in all tissues and therewas
a signiﬁcant age-dependent decrease in MMP2mRNA in the SAN head
and atrial muscle at least (Fig. 7A). In summary, these data provide a
complex picture of age-dependent remodelling of the extracellular
matrix: a modest increase in the abundance of ﬁbrotic agents and a
modest decrease in MMP2 (at mRNA level), both of which will
promote ﬁbrosis, and yet a decrease in abundance of mRNAs
responsible for structural elements of the extracellular matrix.
In addition to the above, we observed no age-dependent change in
a variety of other extracellular matrix components at the mRNA level:
ﬁbronectin α1 (adhesive protein), decorin (anti-ﬁbrotic proteoglycan),
connective tissue growth factor (CTGF; cysteine-rich protein induced
by TGFβ1 and able to trigger many cellular processes underlying
ﬁbrosis), and integrins α1, α5, and β1 (membrane receptors, which
mediate cell–extracellular matrix interactions [24]; data not shown).
MMP1 (a and b types), MMP9 and MMP13 mRNAs were undetectable.
Li et al. [25] also reported that MMP1 is undetectable in rat heart.
4. Discussion
This study has shown that the age-dependent decline in SAN
function is associated with a structural remodelling of the SAN: an
expansion of Nav1.5-negative/HCN4-positive tissue, a hypertrophy of
the SAN cells and a remodelling of the extracellular matrix.
4.1. Age-dependent change in SAN function
The intrinsic heart rate was slower (i.e. intrinsic cycle length was
longer) in theoldanimals (Data Supplement, Fig. S1). The sameoccurs in
the human: although the normal heart rate (under control of autonomic
tone) does not changewith age, the intrinsic heart rate (heart rate in the
absence of autonomic inﬂuence) declines from 107 beats/min at
25 years of age to 70 beats/min at 85 years of age [26]. The same
decline has been observed in a variety of mammalian species [3].
4.2. Age-dependent enlargement of SAN
Intracellular action potential recording demonstrated an age-
dependent increase in the extent of pacemaker tissue with a slow
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qualitatively consistent with the study of Alings and Bouman [3], who
showed that with age the surface area of pacemaker tissue with a slow
action potential increases from 0.20 to 5.48mm2 in the rabbit and from
0.04 to 2.08 mm2 in the cat. The upstroke of the SAN action potential is
slow, because SAN tissue lacks INa andNav1.5 and this study showed that
the age-dependent increase in pacemaker tissue with a slow action
potential is likely to be a consequence of a similar increase in the tissue
lacking expression of Nav1.5 (Table 1). In the present study, in both
young and old animals, the tissue that lacked expression of Nav1.5
expressedHCN4 (Figs. 3 and 4), but not Cx43 (data not shown)—Cx43 is
a gap junctionchannel known tobepresent in theworkingmyocardium,
but absent from the SAN. It follows, therefore, that there was an age-
dependent increase of Nav1.5-negative/HCN4-positive/Cx43-negative
tissue. In the guinea pig, we have previously shown an age-dependent
increase in SAN tissue lacking expression of Cx43 and Cav1.2 (major L-
type Ca2+ channel isoform in working myocardium) [27,28]. Interest-
ingly, in the guinea pig, the increase of the SAN is greater than can be
explained by any increase in heart size [27]. This study has shown that
the enlargement of the SAN can be explained by a hypertrophy of the
SAN cells (Fig. 6).
What are the functional correlates of the increase in the SAN? In the
young animals,with a higher intrinsic heat rate, the leadingpacemaker
site was located near the superior vena cava, whereas in the old
animals, with a lower intrinsic heart rate, the leading pacemaker site
was located more inferiorly nearer the inferior vena cava (Table 1).
This is consistent with the extension of pacemaker tissue towards the
inferior vena cava in the old animals (Table 1). It is also consistentwith
the concept of the SAN containing a hierarchy of pacemakers: Boineau
et al. [29] have suggested that within the SAN there is a hierarchy of
pacemakers and, the more inferior the position in the SAN, the slower
the heart rate. The increase in SAN tissue lacking expression of Nav1.5
possibly could help explain the increase in the SAN conduction time
observed in the elderly and SAN exit block in sick sinus syndrome [30]
if the SAN action potential has to propagate a greater distance from the
leading pacemaker site in the SAN through tissue lacking Nav1.5 to
reach the surrounding atrialmuscle [2]. Blockade of Nav1.5 (e.g. Fig. 1),
knockout of Nav1.5 and loss of function mutations in Nav1.5 also cause
bradycardia [2,4]. However, the increase in SAN tissue lacking
expression of Nav1.5 cannot explain the age-dependent decrease in
the intrinsic heart rate, because blockade of Nav1.5 by 2 μM TTX had a
greater effect on the heart rate in the old animals (Fig. 1). Blockade
of HCN4 also had a greater effect on the heart rate in the old animal
(Fig. 1). The greater sensitivity of SAN pacemaking in old animals to
blockade of Nav1.5 and HCN4 possibly results from a shift in the
relative contribution of different ionic mechanisms to pacemaking. If
the decrease in the intrinsic heart rate during ageing is the result of
another factor (e.g. decrease of L-type Ca2+ current [28] or ‘Ca2+
clock [31]), blockade of Nav1.5 and HCN4 may result in a larger
effect in the old animal. This implies that there is a decrease in
‘pacemaking reserve’ in the old animal. If this is the case, a drug or
naturally occurring mutation that results in a loss-of-function of an
ion channel will cause a more serious bradycardia in the elderly.
4.3. Age-dependent remodelling of interstitium
Older literature claims that there is an age-dependent increase in
the collagen protein content of the SAN and this is responsible for the
decline in SAN function [8]. However, Alings et al. [8] criticised these
studies, because of the non-speciﬁcity of the dyes used for collagen
measurement. Alings et al. [8] used Picro Sirius red to measure
collagen protein and they reported that in the human SAN, from
adulthood, there is no age-dependent increase in collagen protein and
there is also no age-dependent change in the cat SAN. Nevertheless, an
age-dependent increase in the interstitium and a loss of nodal cells
has recently been reported in the rat [9].This is the ﬁrst study to investigate the effects of ageing on the
components of the interstitium. In the present study, in the SAN of old
animals, there was no overt evidence of an increase of the interstitium
and a loss of nodal cells in Masson's trichrome stained sections (Fig.
6A; cf [27]). The two main components of the interstitium are
ﬁbroblasts and collagen (made by ﬁbroblasts) [9]. Consistent with the
observations from the Masson's trichrome stained sections, there was
no age-dependent change in vimentin mRNA and protein (ﬁbroblast
marker; Fig. 7) and, in fact, there was a decrease in collagen protein as
measured by Picro Sirius red (Fig. 7B). The abundance of collagen
protein depends on the balance of the rate of its synthesis from its
mRNA and the rate of its degradation by MMPs. Although there was a
modest age-dependent decrease in MMP2 mRNA (Fig. 7A; tending to
result in increase in collagen protein), there was a large age-
dependent decrease of mRNAs for types 1 and 3 collagen of ∼79%
(Fig. 7A; tending to result in decrease in collagen protein) and
presumably the latter effect dominated to explain the observed age-
dependent decrease in collagen protein (Fig. 7B). The age-dependent
decrease in collagen mRNAs occurred despite a modest age-
dependent increase in TGFβ1 and TNFα mRNAs (Fig. 7A).
In contrast to the SAN, there appears to be a dramatic age-
dependent increase in the interstitium and collagen protein content in
the rat ventricles [32,33]. For example, from 3- to 24-month-old rats,
Besse et al. [33] reported a 346% increase in collagen protein in the
ventricles. Despite this possible difference between the SAN and
ventricles, the underlying changes in the two tissues are likely to be
the same. Consistent with the changes observed in the present study,
from 3- to 24-month-old rats, Besse et al. [33] observed decreases of
mRNAs for types 1 and 3 collagen of ∼50% in the ventricles. Consistent
with this and the results from the present study, from 1- to 24-month-
old rats, Mays et al. [34] observed a 10-fold decrease in the rate of
collagen protein synthesis in the heart (whole); they observed similar
changes in the lung and skin. Again consistent with the changes
observed in the present study, from young to 24-month-old rats,
Robert et al. [35] observed a 40% decrease in MMP2 activity and a
corresponding decrease of MMP2 mRNA in the ventricles. In
summary, there are age-dependent decreases of both collagen and
MMPmRNAs. It is possible that, in the ventricles, the decrease inMMP
mRNA is the dominating inﬂuence and, consequently, there is an age-
dependent increase in collagen protein, whereas, in the SAN, the
decreases of collagen and MMP mRNAs are more balanced and there
can be no age-dependent change in collagen protein [8] or even a
decrease as in the present study.
It is concluded that the age-dependent decline in SAN function is
associated with a structural remodelling of the SAN: an increase in SAN
tissue, a hypertrophy of the SAN cells and a remodelling of the
extracellular matrix. The implications of the structural remodelling
associatedwith ageing and/or obesitywill require further investigation.
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